Print Page Print Page
E-mail Page E-mail Page
RSS Feeds RSS Feeds
X
Share Page Share Page
E-mail Alerts E-mail Alerts
Financial Tear Sheet Financial Tear Sheet

2017 Press Releases

2017 | 2016 | 2015 | Previous Releases
September 13, 2017
Otonomy Provides Business and Financial Update
August 30, 2017
Otonomy Reports Results for AVERTS-1 Phase 3 Trial for OTIVIDEX™ in Patients with Ménière's Disease
August 03, 2017
Otonomy Reports Second Quarter 2017 Financial Results and Provides Corporate Update
July 27, 2017
Otonomy to Report Second Quarter 2017 Financial Results and Provide Corporate Update
July 18, 2017
Otonomy Announces FDA Acceptance of OTIPRIO® Supplemental New Drug Application Filing for Acute Otitis Externa
June 22, 2017
Otonomy Announces Successful End-of-Phase 2 Review by FDA for OTIPRIO® in Acute Otitis Media with Tympanostomy Tubes
June 20, 2017
Otonomy to Host Key Opinion Leader Meeting for Investors on Ménière's Disease
May 12, 2017
Otonomy Announces OTIPRIO® Data Presentation and Symposium at the American Society of Pediatric Otolaryngology Annual Meeting
May 10, 2017
Otonomy to Present at the Bank of America Merrill Lynch Health Care Conference
May 04, 2017
Otonomy Reports First Quarter 2017 Financial Results and Provides Corporate Update
April 27, 2017
Otonomy to Report First Quarter 2017 Financial Results and Provide Corporate Update
March 02, 2017
Otonomy Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
February 28, 2017
Otonomy to Present at Cowen and Company Health Care Conference
February 24, 2017
Otonomy to Report Fourth Quarter and Full Year 2016 Financial Results and Provide Corporate Update
January 19, 2017
Otonomy Initiates Patient Enrollment in Phase 2 Clinical Trial of OTO-104 as Protectant Against Cisplatin-Induced Hearing Loss
January 09, 2017
Otonomy Provides Corporate and Product Pipeline Update
January 05, 2017
Otonomy Announces Positive Top-Line Results from Phase 3 Clinical Trial of OTIPRIO® in Patients with Acute Otitis Externa
January 03, 2017
Otonomy to Present at the J.P. Morgan Healthcare Conference